Cure TV

Ryan Cohlhepp, from Takeda Oncology, discusses the accomplishments of the Moving Mountains for Multiple Myeloma team. Cohlhepp, along with other members of the team, were honored at our 2016 Multiple Myeloma Heroes event.

Jeff Goad and his wife, Ramona Biliunas, discuss why the climbed Mount Kilimanjaro as part of the Moving Mountains for Multiple Myeloma team. Jeff was also one of our 2016 Multiple Myeloma Heroes.

Jason Katz, who accepted the 2016 Multiple Myeloma Hero award for his late father, Mike Katz, discusses how his father became inspired and motivated to help others with multiple myeloma. Mike Katz, who was a board member of the International Myeloma Foundation, passed away last year after battling the disease for more than two decades.

Bob Dickey, a survivor of multiple myeloma, discusses the importance of the relationships formed when he and more than 80 other people climbed Mount Kilimanjaro.

Marlee Matlin, an Academy award-winning actress, discusses her father’s diagnosis and journey with multiple myeloma.

Susan Melvin Hill, patient advocate, tells her MPN story and discusses how she helps patients with myeloproliferative neoplasms (MPNs) in Idaho.

Jason R. Gotlib discusses JAK inhibitors for the treatment of patients with myelofibrosis.

Kareem Abdul-Jabbar, NBA Legend and chronic myeloid leukemia (CML) survivor, provides advice for newly diagnosed patients with CML.

David Dubin, founder, AliveAndKickn, provides advice for Lynch syndrome previvors.

Amy Robach gives advice to patients on how to avoid feeling overwhelmed when choosing a treatment plan for breast cancer.

Despite three bouts with cancer, David Dubin still continued to play soccer. Now, not only is he persevering on the soccer field, but in the field of cancer as well. Dubin and his wife, Robin, founded AliveAndKickin. This organization works toward bettering the lives of people like Dubin who have Lynch Syndrome, which gives a genetic predisposition to cancer.

Dr. Maurie Markman sits down with Dr. Vincent T. DeVita, one of the most influential researchers and physicians in the cancer care arena.

Dr. Maurie Markman sits down with Dr. Vincent T. DeVita, one of the most influential researchers and physicians in the cancer care arena.

Dr. Maurie Markman sits down with Dr. Vincent T. DeVita, one of the most influential researchers and physicians in the cancer care arena.

Dr. Maurie Markman sits down with Dr. Vincent T. DeVita, one of the most influential researchers and physicians in the cancer care arena.

CURE spoke to Friedman during the 2016 Cancer Survivorship Symposium in mid-January.

We spoke with Oeffinger during the 2016 Cancer Survivorship Symposium in mid-January.

Danielle Nicosia, a survivor of thyroid cancer, discusses being misdiagnosed.

McCabe addressed this topic and others in her talk, "Models of Delivery" at the 2016 Cancer Survivorship Symposium in San Francisco.

Safran is the Executive Director of The Identity Shift Project, which aims to bring new perspectives to healing through collaborative art making.

Kay Verble discusses a research endeavor to characterize long-term survivors of glioblastoma multiforme (GBM).

Karen Duffy pays tribute to her husband, Harvey Lawrence Gould, who was named one of our 2015 MPN Heroes.

Greg Cantwell, a survivor of glioblastoma multiforme (GBM) and the founder of Greg's Mission, discusses the need to support and educate patients with GBM.

Jason R. Gotlib discusses the research being done at his institution. Gotlib is a 2015 MPN Hero in the category of Commitment to the Individual and is also an international leader in MPN research.

David T. Boule discusses the challenges and rewards of patient advocacy.

Sherry Fox accepts her award as one of our 2015 GBM Heroes.

Santosh Kesari discusses the need to think outside the box when conducting research in glioblastoma multiforme (GBM).

Rebecca N. Claassen discusses the importance of educating nurses about myeloproliferative neoplasms (MPNs).

Susan Melvin Hill, patient advocate, discusses how she meets with and helps patients with myeloproliferative neoplasms (MPNs) in Idaho.